Helena C. Maltezou MD, PhD , Maria N. Gamaletsou MD, PhD , Theodoros V. Giannouchos PhD, MS, MPharm , Dimitra-Maria Koukou MD, PhD , Flora Sourri RN , Nikolaos Lemonakis RN , Amalia Karapanou RN , Sofia Zerva RN , Athanasia Lourida MD, PhD , Periklis Panagopoulos MD, PhD , Dimitrios Hatzigeorgiou MD, PhD , Nikolaos V. Sipsas MD, PhD
{"title":"2023-2024年医务人员中SARS-CoV-2和季节性流感的发病率和缺勤率:希腊的一项多中心队列研究","authors":"Helena C. Maltezou MD, PhD , Maria N. Gamaletsou MD, PhD , Theodoros V. Giannouchos PhD, MS, MPharm , Dimitra-Maria Koukou MD, PhD , Flora Sourri RN , Nikolaos Lemonakis RN , Amalia Karapanou RN , Sofia Zerva RN , Athanasia Lourida MD, PhD , Periklis Panagopoulos MD, PhD , Dimitrios Hatzigeorgiou MD, PhD , Nikolaos V. Sipsas MD, PhD","doi":"10.1016/j.ajic.2025.03.149","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>To assess the morbidity and absenteeism due to SARS-CoV-2 infection or influenza among health care personnel (HCP) in Greece in 2023 to 2024.</div></div><div><h3>Methods</h3><div>We followed 5,871 HCP from November 2023 to May 2024. A multivariable regression was used to estimate the association between length of absenteeism, HCP characteristics, and type of infection.</div></div><div><h3>Results</h3><div>There were 759 episodes of absenteeism during the study period. The mean duration of absence per episode was 4.5<!--> <!-->days and the total duration of absence was 3,434<!--> <!-->days. COVID-19 was diagnosed in 507 (8.6%) HCP, asymptomatic SARS-CoV-2 infection in 10 (0.2%) HCP, and influenza in 88 (1.5%). COVID-19, influenza, and asymptomatic SARS-CoV-2 infection accounted for 66.8%, 11.6%, and 1.3% of episodes of absenteeism, respectively. Overall, SARS-CoV-2 infection and influenza accounted for 76.5% and 9.7% of total days missed, respectively. Presenteeism was recorded in 113 (14.9%) HCP. The multivariable regression model found that having SARS-CoV-2 infection and having at least 1 comorbidity were associated with a mean of 1.76 and 0.25 more days of work absence compared with those with no SARS-CoV-2 infection and no comorbidity, respectively (confidence intervals: 1.55-1.98 and 0.05-0.46, respectively).</div></div><div><h3>Conclusions</h3><div>COVID-19 remains the major driver of absenteeism among HCP.</div></div>","PeriodicalId":7621,"journal":{"name":"American journal of infection control","volume":"53 6","pages":"Pages 685-689"},"PeriodicalIF":3.8000,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Morbidity and absenteeism due to SARS-CoV-2 and seasonal influenza in health care personnel during the 2023 to 2024 season: A multicenter cohort study in Greece\",\"authors\":\"Helena C. Maltezou MD, PhD , Maria N. Gamaletsou MD, PhD , Theodoros V. Giannouchos PhD, MS, MPharm , Dimitra-Maria Koukou MD, PhD , Flora Sourri RN , Nikolaos Lemonakis RN , Amalia Karapanou RN , Sofia Zerva RN , Athanasia Lourida MD, PhD , Periklis Panagopoulos MD, PhD , Dimitrios Hatzigeorgiou MD, PhD , Nikolaos V. Sipsas MD, PhD\",\"doi\":\"10.1016/j.ajic.2025.03.149\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>To assess the morbidity and absenteeism due to SARS-CoV-2 infection or influenza among health care personnel (HCP) in Greece in 2023 to 2024.</div></div><div><h3>Methods</h3><div>We followed 5,871 HCP from November 2023 to May 2024. A multivariable regression was used to estimate the association between length of absenteeism, HCP characteristics, and type of infection.</div></div><div><h3>Results</h3><div>There were 759 episodes of absenteeism during the study period. The mean duration of absence per episode was 4.5<!--> <!-->days and the total duration of absence was 3,434<!--> <!-->days. COVID-19 was diagnosed in 507 (8.6%) HCP, asymptomatic SARS-CoV-2 infection in 10 (0.2%) HCP, and influenza in 88 (1.5%). COVID-19, influenza, and asymptomatic SARS-CoV-2 infection accounted for 66.8%, 11.6%, and 1.3% of episodes of absenteeism, respectively. Overall, SARS-CoV-2 infection and influenza accounted for 76.5% and 9.7% of total days missed, respectively. Presenteeism was recorded in 113 (14.9%) HCP. The multivariable regression model found that having SARS-CoV-2 infection and having at least 1 comorbidity were associated with a mean of 1.76 and 0.25 more days of work absence compared with those with no SARS-CoV-2 infection and no comorbidity, respectively (confidence intervals: 1.55-1.98 and 0.05-0.46, respectively).</div></div><div><h3>Conclusions</h3><div>COVID-19 remains the major driver of absenteeism among HCP.</div></div>\",\"PeriodicalId\":7621,\"journal\":{\"name\":\"American journal of infection control\",\"volume\":\"53 6\",\"pages\":\"Pages 685-689\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-03-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American journal of infection control\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0196655325002846\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of infection control","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0196655325002846","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Morbidity and absenteeism due to SARS-CoV-2 and seasonal influenza in health care personnel during the 2023 to 2024 season: A multicenter cohort study in Greece
Background
To assess the morbidity and absenteeism due to SARS-CoV-2 infection or influenza among health care personnel (HCP) in Greece in 2023 to 2024.
Methods
We followed 5,871 HCP from November 2023 to May 2024. A multivariable regression was used to estimate the association between length of absenteeism, HCP characteristics, and type of infection.
Results
There were 759 episodes of absenteeism during the study period. The mean duration of absence per episode was 4.5 days and the total duration of absence was 3,434 days. COVID-19 was diagnosed in 507 (8.6%) HCP, asymptomatic SARS-CoV-2 infection in 10 (0.2%) HCP, and influenza in 88 (1.5%). COVID-19, influenza, and asymptomatic SARS-CoV-2 infection accounted for 66.8%, 11.6%, and 1.3% of episodes of absenteeism, respectively. Overall, SARS-CoV-2 infection and influenza accounted for 76.5% and 9.7% of total days missed, respectively. Presenteeism was recorded in 113 (14.9%) HCP. The multivariable regression model found that having SARS-CoV-2 infection and having at least 1 comorbidity were associated with a mean of 1.76 and 0.25 more days of work absence compared with those with no SARS-CoV-2 infection and no comorbidity, respectively (confidence intervals: 1.55-1.98 and 0.05-0.46, respectively).
Conclusions
COVID-19 remains the major driver of absenteeism among HCP.
期刊介绍:
AJIC covers key topics and issues in infection control and epidemiology. Infection control professionals, including physicians, nurses, and epidemiologists, rely on AJIC for peer-reviewed articles covering clinical topics as well as original research. As the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC)